Background: The root of Icacina senegalensis is used for the treatment of malaria and related conditions in southeastern Nigeria. Methods: To establish its efficacy, the ethanolic root bark extract was investigated as antiplasmodial agent against Plasmodium berghei in mice. A 4-day suppressive test and the curative effect against established infection models of antiplasmodial studies were used. Results: The root bark extract of I. senegalensis (50, 100, and 200 mg/kg) exhibited a significant (p < 0.05) dosedependent activity against the parasite based on suppressive and curative study. The antimalarial effect of I. senegalensis is compared with that of chloroquine (10 mg/kg), the standard drug. The ethanolic root bark extract also prolonged the survival time of infected mice.
Introduction
Malaria remains one of the dreaded diseases globally, killing more than 500 million people annually [1] . The most serious manifestations of malaria are caused by Plasmodium falciparum. Antimalarial drug resistance has emerged as one of the strongest challenges presently facing malaria control in developing countries. The drug resistance has also been implicated in the spread of malaria to new areas and the reemergence of the disease in areas where it has been destroyed [2, 3] . More recently, the situation has worsened because malaria parasites are becoming resistant to several antimalarial agents [4, 5] . The use of medicinal plants for the treatment of diseases has long been in practice [6] . Medicinal plants have been used in almost all cultures as a source of medicine [7] .
Icacina senegalensis A. Juss, which belongs to the family of Icacinaceae, is a savanna leafy shoot with a height of 2-3 feet and a large tuber with creeping roots. The plant is mostly found in west and central Africa [8, 9] . The leaves and root bark are used as antihyperglycemia, antimalarial, and antimicrobial [10] [11] [12] [13] .
The aim of the present study was to evaluate the antiplasmodial potential of the ethanolic root bark extract of I. senegalensis in mice infected by Plasmodium berghei.
Materials and methods

Plant collection and sample preparation
The root bark materials of I. senegalensis were collected from Orlu, Imo state, Nigeria. Identification of the plant was done at the Herbarium of the Department of Botany, University of Calabar, where a voucher specimen (no. 620) is maintained. The root bark was airdried and ground to powder using mortar and pestle. One hundred and fifty grams of the grounded root bark of I. senegalensis was soaked in 1.5 L of ethanol for 48 h at room temperature. The extract was filtered and the solvent was evaporated on organ bath at reduced temperature (25 °C) . The recovered extract weighing 15 g (10% w/w) was kept in a sample bottle in the refrigerator until used.
Phytochemical analysis
The ethanolic root bark extract of I. senegalensis was subjected to phytochemical analysis to determine the secondary metabolites following the procedures of Oloyede [14] and Mukherjee [15] .
Acute toxicity test
The acute toxicity of the ethanolic extract was determined by evaluating the median lethal dose using the method described by Lorke [16] . Doses ranged from 10 to 5000 mg/kg orally. Mice were kept under similar conditions and observed to detect signs of toxicity and mortality rates at 24 and 72 h.
Animals
Swiss albino mice (18-22 g) of both sexes raised at the Animal house of Ebonyi State University, Abakaliki, were used in the study. The mice were maintained on standard pellet and water ad libitum. The protocol was done according to the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health [17] .
Parasite
The chloroquine-sensitive Plasmodium berghei NK65 strain obtained from the National Institute for Medical Research was used for the study. The parasites were maintained by continuous reinfestation in mice.
Infection of mice with P. berghei
All mice were passaged intraperitoneally from the donor-infected mouse. The P. berghei-infected erythrocytes were intraperitoneally administered into the mice on day 1 from the parasitized erythrocytes diluted with normal saline. Accordingly, each 0.2 mL had approximately 1 × 107 P. berghei
In vivo antiplasmodial study
Suppressive study: A total of 30 mice were used for the study. They were divided into five groups of six mice per cage. Different doses of the root bark extract (50, 100, and 200 mg/kg) were administered via cannula to the mice under study. The group administered chloroquine diphosphate (10 mg/kg) acts as positive control, whereas the group given normal saline (20 mL/kg) was a negative control for 4 days. On the fifth day, thick films from the tail blood were prepared and fixed in methanol. The films were air-dried and then stained with Giemsa and examined by light microscopy (Olympus CX 21, Japan) to determine the parasite density of each mouse. The percentage suppression of parasitemia was determined in both groups [18] .
Curative study: Seventy-two hours after infecting the mice with P. berghei, the animals were the divided into five groups of six mice per cage. Different doses of the root bark extract (50, 100, and 200 mg/kg) were administered orally to the mice under study. Chloroquine diphosphate (10 mg/kg) and normal saline (20 mL/kg) were administered to the positive and negative control, respectively. Treatment continued once daily for 3 days. Thick films were later prepared from the tail blood of each mouse and allowed to air-dry. The films were fixed in methanol, stained with Giemsa, and microscopically viewed to determine the parasitemia density each group. The mean survival time for each group was determined by finding the average survival time of the mice (days) in each group for a period of 28 days [19] .
Statistical analysis
Results are presented as mean ± standard error of the mean. A oneway analysis of variance was used to analyze and compare the data, with p < 0.05 as the limit of significance [20] .
Results
Phytochemical tests
Phytochemical screening of the root bark of I. senegalensis has revealed the presence of alkaloids, flavonoids, saponins, tannins, cardiac glycosides steroids, terpenoids, and anthraquinone and the absence of phlobatannins.
Oral acute toxicity tests
The oral acute toxicity sign observed in mice was paw licking. There was no mortality observed at 3000 mg/kg; thus, the experimental doses used (50, 100, and 200 mg/kg) were relatively safe in mice. Table 1 shows the antiplasmodial profile of the root bark extract of I. senegalensis assessed using the 4-day suppressive study in mice. The extract at all doses used had significant (p < 0.05) and dose-dependent antiplasmodial activity. The root bark extract had 81%, 86%, and 92% chemosuppressive activity, whereas the reference drug chloroquine had 95% inhibition. At 200 mg/kg, the ethanol root bark extract of I. senegalensis exhibited 92% suppression of parasitemia comparable with 95% that of chloroquine (positive control). Table 2 shows the antiplasmodial profile of I. senegalensis root bark extract assessed using the established P. berghei in mice. Icacina senegalensis at all doses used caused a significant (p < 0.05) and dose-dependent decrease in parasitemia, although lower than the reference drug (chloroquine)-treated group. However, the control group (negative) showed daily increase in parasitemia density, which was equally observed in our previous studies [12, 21] . However, it was observed that the root bark extract significantly prolonged survival time in infected mice after discontinuation of treatment in established infection (Table 3) .
Suppressive activity
Discussion
Medicinal plants have always played an essential role in the management of community health and discovery of novel antimalarial agent. These plants could be attractive starting materials as they are widespread. Moreover, a large population, especially in developing countries, relies on them for their curative activities. The traditional use of I. senegalensis for the treatment of malaria could be attributed to the presence of certain phytochemicals that constitute the bioactive principles. Numerous medicinal plants containing a wide variety of secondary metabolites have shown antiplasmodial activities [22, 23] .
The 4-day suppressive test is a standard test that is commonly used for the evaluation of antimalarial, and the determination of the percentage inhibition of parasitemia density is the most reliable parameter. However, the observed result showed that in P. berghei-infected mice treated with the ethanolic root bark of I. senegalensis, percentage parasitemia significantly changed from the control group. There was a significant suppression of the parasites by the root bark extract. The antimalarial activity shown is consistent with the traditional use of the Significantly different from control at p < 0.05 (n = 6). Significantly different from control at p < 0.05 (n = 6). Significantly different from control at p < 0.05 (n = 6).
plant as herbal remedy against the disease in southeastern Nigeria. The root bark extract of I. senegalensis also exhibited curative activity against established infection and indicative of its potential as a chemotherapeutic antimalarial agent. The extract showed appreciable inhibition against the parasites at all the doses used. Icacina senegalensis root bark also exhibit potent analgesic, anti-inflammatory, and antipyretic properties [24] . These findings support the ethnomedical use of this plant in the treatment of malaria and associated symptoms. Chloroquine, which has been used for suppressive and curative antiplasmodial activities [25, 26] , was used in this study. Although chloroquine exhibited higher suppressive and curative antiplasmodial activities by the extent of decrease in parasitemia, I. senegalensis root bark extract also showed similar antiplasmodial activities, however to a lower potency. The extract also enhanced the mean survival period of the treated mice, especially the group administered with 200 mg/kg of the root bark extract.
In conclusion, the results of the present study have shown that the ethanol root bark extract of I. senegalensis possesses potent antiplasmodial activity and may therefore serve as potential sources of effective and affordable antimalarial agents. The antiplasmodial (in vivo) activity observed makes I. senegalensis a candidate for the bioassay-guided isolation of compounds, which could develop into new lead structure for drug development programs against human malaria.
